261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )

Deadline:N/A

Tender information
Grande Lisboa
Grande Lisboa
Portugal
Type
Contract award
Procedure
Open procedure
Ref. number
261A000098
Estimated value
€71,125
Duration
6 months
C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )

Lote 1 - BEVACIzumab 100MG

BEVACIzumab 100MG/4 ML INJ BIOSSIMILAR FR (OYAVAS)

Lote 2 - BEVACIzumab 400MG

BEVACIzumab 400MG/16 ML INJ BIOSSIMILAR FR (OYAVAS)

Buyer
Unidade Local de Saúde Santa Maria, E.P.E.
buyer-email@mail.com
organization number
Contract award
tenderer iconCICLUM FARMA UNIPESSOAL, LDAtenderer status icon trophyAwarded

Documents

Document name
Upload date
File size
First document.pdf
1 Jan 1970, 00:001 Bytes
Second document.pdf
1 Jan 1970, 00:001 Bytes
Contract awarded
Important dates
13 Jul - Publication date
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Mercell Logo

Feel free to reach out!

Mercell is the leading European provider of e-tendering and procurement systems, and information between buyers and suppliers in the professional market.

We appreciate your input.

© Mercell Group 2026

Terms & Conditions and Privacy Notice

Mercell Group

  • Email: post@mercell.com
  • Phone: +47 21 01 88 00
  • Address: Askekroken 11, 0277 Oslo, Norway

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.